Literature DB >> 3354745

Optimum cutoff points for biochemical validation of smoking status.

S R Cummings1, R J Richard.   

Abstract

Selection of cutoff points for tests to validate smoking cessation should take account of the prevalence of deception. When the prevalence of deception is relatively low, the cutoff points to validate quitting should be relatively high. Many studies have used cutoff points that are too low and may have underestimated cessation rates. We present a method for determining the best cutoff points that takes account of the prevalence of deception.

Mesh:

Year:  1988        PMID: 3354745      PMCID: PMC1349344          DOI: 10.2105/ajph.78.5.574

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

1.  Probability theory in the use of diagnostic tests. An introduction to critical study of the literature.

Authors:  H C Sox
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

2.  Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate.

Authors:  N J Haley; C M Axelrad; K A Tilton
Journal:  Am J Public Health       Date:  1983-10       Impact factor: 9.308

3.  Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking.

Authors:  M A Russell; R Merriman; J Stapleton; W Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

4.  Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers.

Authors:  C J Vesey; Y Saloojee; P V Cole; M A Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-22

5.  Nicotine gum and behavioral treatment in smoking cessation.

Authors:  S M Hall; C Tunstall; D Rugg; R T Jones; N Benowitz
Journal:  J Consult Clin Psychol       Date:  1985-04

6.  Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation.

Authors:  K O Fagerström
Journal:  Prev Med       Date:  1984-09       Impact factor: 4.018

7.  A comparison between carboxyhemoglobin and serum thiocyanate determinations as indicators of cigarette smoking.

Authors:  J D Cohen; G E Bartsch
Journal:  Am J Public Health       Date:  1980-03       Impact factor: 9.308

8.  Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure.

Authors:  T M Vogt; S Selvin; G Widdowson; S B Hulley
Journal:  Am J Public Health       Date:  1977-06       Impact factor: 9.308

9.  The effectiveness of smoking cessation methods for smokers in public health maternity clinics: a randomized trial.

Authors:  R A Windsor; G Cutter; J Morris; Y Reese; B Manzella; E E Bartlett; C Samuelson; D Spanos
Journal:  Am J Public Health       Date:  1985-12       Impact factor: 9.308

10.  Comparison of tests used to distinguish smokers from nonsmokers.

Authors:  M J Jarvis; H Tunstall-Pedoe; C Feyerabend; C Vesey; Y Saloojee
Journal:  Am J Public Health       Date:  1987-11       Impact factor: 9.308

  10 in total
  37 in total

1.  Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988-1994.

Authors:  W Wei; Y Kim; N Boudreau
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

2.  Cardiovascular risk factors in Mexican American adults: a transcultural analysis of NHANES III, 1988-1994.

Authors:  J Sundquist; M A Winkleby
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

3.  Gas stove use and respiratory health among adults with asthma in NHANES III.

Authors:  M D Eisner; P D Blanc
Journal:  Occup Environ Med       Date:  2003-10       Impact factor: 4.402

4.  Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels.

Authors:  L E Wagenknecht; G L Burke; L L Perkins; N J Haley; G D Friedman
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

5.  Prenatal cigarette smoke exposure and early initiation of multiple substance use.

Authors:  Lidush Goldschmidt; Marie D Cornelius; Nancy L Day
Journal:  Nicotine Tob Res       Date:  2011-12-16       Impact factor: 4.244

6.  Training physicians about smoking cessation: a controlled trial in private practice.

Authors:  S R Cummings; R J Richard; C L Duncan; B Hansen; R Vander Martin; B Gerbert; T J Coates
Journal:  J Gen Intern Med       Date:  1989 Nov-Dec       Impact factor: 5.128

7.  Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.

Authors:  Lisa Sanderson Cox; Nicole L Nollen; Matthew S Mayo; Won S Choi; Babalola Faseru; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia
Journal:  J Natl Cancer Inst       Date:  2012-01-25       Impact factor: 13.506

8.  Smokeless tobacco abstinence effects and nicotine gum dose.

Authors:  D Hatsukami; D Anton; R Keenan; A Callies
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Authors:  Richard A Brown; Raymond Niaura; Elizabeth E Lloyd-Richardson; David R Strong; Christopher W Kahler; Ana M Abrantes; David Abrams; Ivan W Miller
Journal:  Nicotine Tob Res       Date:  2007-07       Impact factor: 4.244

10.  Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.

Authors:  Babalola Faseru; Nicole L Nollen; Matthew S Mayo; Ron Krebill; Won S Choi; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia; Lisa Sanderson Cox
Journal:  Addict Behav       Date:  2012-11-29       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.